Holen Sie sich die Stockscreener-App
2.30
2.22%
0.05
Handel nachbörslich:
2.30
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
Nuvation Bio Inc. Ratifies the Appointment of KPMG LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 - marketscreener.com
Nuvation Bio Holds Successful Annual Meeting 2025 - TipRanks
Nuvation Bio stockholders approve board members and executive pay - Investing.com
Nuvation Bio’s SWOT analysis: taletrectinib approval could transform stock outlook - Investing.com Canada
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting - BioSpace
Northern Trust Corp Acquires 563,627 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Brokerages Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $7.83 - Defense World
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - simplywall.st
Wedbush Reiterates Outperform Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUV - GuruFocus
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUVB Stock News - GuruFocus
Dimensional Fund Advisors LP Cuts Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025 - BioSpace
Breakthrough Comparison: How Nuvation's Cancer Drug Stacks Up Against Entrectinib in Crucial Lung Cancer Study - Stock Titan
Nuvation Bio Inc. (NYSE:NUVB) Q1 2025 Earnings Call Transcript - Insider Monkey
Nuvation Bio Inc. (NYSE:NUVB) Shares Bought by Price T Rowe Associates Inc. MD - Defense World
Nuvation Bio to Participate in Upcoming May 2025 Investor Conferences - BioSpace
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength - TipRanks
Nuvation Bio to Participate in Upcoming Investor Conferences - Yahoo
Wedbush Issues Positive Outlook for Nuvation Bio Earnings - Defense World
FY2029 Earnings Forecast for Nuvation Bio Issued By Wedbush - Defense World
Nuvation Bio Inc (NUVB) Q1 2025 Earnings Call Highlights: Promising Developments and Strategic Moves - Investing.com Canada
Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Insider Monkey
Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon - TipRanks
MetLife Investment Management LLC Buys 12,596 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Earnings call transcript: Nuvation Bio Q1 2025 sees strategic focus amid EPS miss - Investing.com
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Reports Q1 2025 Results and Business Updates - TipRanks
Nuvation Bio (NUVB) Eyes U.S. Approval for Key Lung Cancer Treat - GuruFocus
Nuvation Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Stock Performance Spotlight: Nuvation Bio Inc (NUVB) Ends the Day at 2.09, Down by -12.18 - DWinneX
Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (NYSE:NUVB) - Seeking Alpha
Wells Fargo & Company MN Increases Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Shares Down 8.2% After Insider Selling - Defense World
Nuvation Bio Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Sells 322,798 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NUVB) Stock: A Year of Stock Market Dynamics - investchronicle.com
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
LPL Financial LLC Grows Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at The Citizens Life Sciences Conference - BioSpace
Nuvation Bio Inc [NUVB] Records 50-Day SMA of $1.98 - knoxdaily.com
Nuvation Bio Inc (NUVB) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Nuvation Bio Inc (NUVB)’s stock price range in the last year - uspostnews.com
Renaissance Technologies LLC Has $1.51 Million Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Legal & General Group Plc Buys 62,877 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc [NUVB] Investment Guide: What You Need to Know - knoxdaily.com
An Overview of Nuvation Bio Inc (NYSE: NUVB)’s Stock Performance and Outlook - Marketing Sentinel
Russell Investments Group Ltd. Buys 15,791 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from Analysts at JMP Securities - Defense World
Nuvation Bio (NYSE:NUVB) Earns Mkt Outperform Rating from Analysts at Citizens Jmp - Defense World
17.27%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):